2026 · 2nd Quarter (Apr 1 - June 30)

ZIMMER BIOMET, INC.

Filed by ZIMMER BIOMET, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 15, 2026
Income: Not reported
Expenses: $190,000.00
Registrant: ZIMMER BIOMET, INC.
Client: ZIMMER BIOMET, INC.
Filing UUID: 902e8d0d-cdfb-4333-9019-c89018d1101c
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;

Literal federal measure citations: H.R. 3006, S. 1776

TRD · Trade (domestic/foreign)

Trade Issues/Policy

TAX · Taxation/Internal Revenue Code

Tax Issues; Medical Device Tax repeal

CHM · Chemicals/Chemical Industry

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

MED · Medical/Disease Research/Clinical Labs

Breakthrough devices;

SCI · Science/Technology

e-labeling; Breakthrough devices

TAR · Tariff (miscellaneous tariff bills)

Tariff policy

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.